Neuropathological validation of plasma GFAP
Andréa Lessa Benedet(University of Pittsburgh), Douglas Galasko(University of Minnesota), Eduardo R. Zimmer(Universidade Federal do Rio Grande do Sul), Kaj Blennow(Sahlgrenska University Hospital), Juan Lantero‐Rodriguez(University of Gothenburg), Denis S. Smirnov(University of California San Diego), Henrik Zetterberg(University of Wisconsin–Madison), Nicholas J. Ashton(King's College London), Annie OF Hiniker(University of California San Diego), Joel Simrén(University of Gothenburg)
Cited by 9
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k